Bleeding risk after percutaneous endoscopic gastrostomy (PEG) with simultaneous treatment of aggressive antithrombotic-drug regimens
- Conditions
- bleeding risk after PEG with and without antithrombotic drug regimesrisk of peritonitis after PEG with and without antithrombotic drug regimesrisk of infection after PEG with and without antithrombotic drug regimesSurgery - Surgical techniques
- Registration Number
- ACTRN12608000194369
- Lead Sponsor
- Albert Ludwigs University Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
All 1057 patients referred between September 2001 and March 2007 to the endoscopic department of the Surgical Hospital at the University of Freiburg from in-house or external specialist departments (Neurology, Radiology, Clinic for Anesthesia, Cardiac Surgery and Orthodontic Surgery, ENT and Pediatrics and the International Medical Service -IMS) with the indication for percutaneous endoscopic gastrostomy (PEG) were enrolled according to predefined exclusion criteria
further criteria
cirrhosis
nicotinism
obesity
diabetes mellitus
coagulopathy
malignancy
neurological disorders
inflammatory disorders
radiation therapy
chemo therapy
alcoholism
ENT: Esopageal-Naso-Throat Hospital
The following exclusion criteria were defined: Patients in whom no standard pull-through” technique with or without prior Savary-Gilliard bouginage (SG-bouginage) in stenosis of the hypopharynx or esophagous was possible, patients in whom the PEG could not be placed without additional imaging (computer tomography), and patients in whom PEG placement had to be terminated prior to completion due to respiratory or other complications, or patients who died within the first 7 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method